GPCRs are reported to control critical pro-survival and stress-signaling pathways that are often dysregulated in human cancer to favor cancer cell survival and progression [16], and DRD2 are often overexpressed by tumor cells and can be activated by dopamine produced in its tumor microenvironment or by the tumor cells themselves [14]. The gene discussed is DRD2; the disease is neoplasm.